BioSpace News Archive

Bio NC

IQVIA CFO Ron Bruehlman to Speak at Morgan Stanley Annual Global Healthcare Conference on September 13, 2022

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Morgan Stanley Annual Global Healthcare Conference in New York City on Tuesday, September 13, 2022 at 11:10 a.m. ET.

September 1, 2022
·
1 min read
Biotech Beach

Dexcom Announces Upcoming Conference Presentations in September 2022

DexCom, Inc. announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the following upcoming investor conferences.

September 1, 2022
·
1 min read
Pharm Country

VBL Therapeutics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

VBL Therapeutics announced that VBL received a written notification from the Nasdaq Stock Market LLC on August 31, 2022, notifying VBL that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.

September 1, 2022
·
4 min read
Biotech Bay

Geron to Present at Upcoming September 2022 Investor Conferences

Geron Corporation announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present in-person at the following investor conferences in New York City.

September 1, 2022
·
1 min read
Genetown

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 01, 2022

ImmunoGen, Inc. announced that on August 31, 2022, the compensation committee of the Company’s Board of Directors approved grants of non-qualified stock option awards to purchase an aggregate of 883,720 shares of its common stock to twenty-four new employees under the ImmunoGen, Inc.

September 1, 2022
·
2 min read
Pharm Country

Cellectis Announces Participation in Four Upcoming Investor Conferences in September 2022 - Sep 01, 2022

Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced that management plans to participate in four upcoming investor conferences.

September 1, 2022
·
4 min read
Biotech Beach

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sep 01, 2022

Zentalis™ Pharmaceuticals, Inc. announced that on September 1, 2022, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 125,000 shares of its common stock to one new employee.

September 1, 2022
·
2 min read
Biotech Bay

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 01, 2022

Olema Pharmaceuticals, Inc. announced that the Company granted stock options to three new employees to purchase an aggregate of 72,200 shares of the Company’s common stock, effective as of September 1, 2022.

September 1, 2022
·
1 min read
BioCapital

Danaher to Webcast Bioprocessing Investor and Analyst Meeting at Cytiva

Danaher Corporation will host a live video webcast of its Bioprocessing Investor and Analyst Meeting at Cytiva on September 15, 2022 beginning at approximately 12:00 p.m. ET.

September 1, 2022
·
1 min read
Biotech Bay

Veracyte to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, at 2:55 p.m. Eastern Time.

September 1, 2022
·
1 min read